| P50 | author | Sarosh R Irani | Q47819572 |
| P2093 | author name string | Bethan Lang | |
| P2860 | cites work | Myokymia and neonatal epilepsy caused by a mutation in the voltage sensor of the KCNQ2 K+ channel | Q24555140 |
| | IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel | Q24646531 |
| | Sub-acute presentation of Morvan's syndrome after thymectomy | Q24671712 |
| | Subunit composition of Kv1 channels in human CNS | Q28140821 |
| | Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis | Q28244864 |
| | Autoantibodies to glutamate receptor GluR3 in Rasmussen's encephalitis | Q28245345 |
| | Steroid-responsive encephalopathy associated with autoimmune thyroiditis | Q28297234 |
| | Neuronal surface glycolytic enzymes are autoantigen targets in post-streptococcal autoimmune CNS disease | Q28579383 |
| | Ablation of P/Q-type Ca(2+) channel currents, altered synaptic transmission, and progressive ataxia in mice lacking the alpha(1A)-subunit | Q28592875 |
| | A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis | Q29615952 |
| | Potentially reversible autoimmune limbic encephalitis with neuronal potassium channel antibody | Q30920813 |
| | Acute limbic encephalitis: a new entity? | Q31026952 |
| | CSF B-cell expansion in opsoclonus-myoclonus syndrome: a biomarker of disease activity | Q31094772 |
| | Proteomic analysis of human brain identifies alpha-enolase as a novel autoantigen in Hashimoto's encephalopathy. | Q31111353 |
| | Paraneoplastic cerebellar ataxia due to autoantibodies against a glutamate receptor | Q33179400 |
| | A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica | Q33727402 |
| | Missense mutations in the regulatory domain of PKC gamma: a new mechanism for dominant nonepisodic cerebellar ataxia | Q33905051 |
| | Anti-striatal antibodies in Tourette syndrome cause neuronal dysfunction | Q33924303 |
| | Morvan's syndrome: peripheral and central nervous system and cardiac involvement with antibodies to voltage-gated potassium channels | Q34101039 |
| | The humoral response in the pathogenesis of gluten ataxia | Q34125029 |
| | Mimicry and autoantibody-mediated neuronal cell signaling in Sydenham chorea. | Q34207767 |
| | Immunity and behavior: antibodies alter emotion | Q34270963 |
| | Acquired neuromyotonia: evidence for autoantibodies directed against K+ channels of peripheral nerves | Q34289244 |
| | Striatal microinfusion of Tourette syndrome and PANDAS sera: failure to induce behavioral changes | Q34312538 |
| | B- and T-cell markers in opsoclonus-myoclonus syndrome: immunophenotyping of CSF lymphocytes. | Q34319968 |
| | Absence of antibodies to glutamate receptor type 3 (GluR3) in Rasmussen encephalitis | Q34332988 |
| | Medical treatment of Rasmussen's syndrome (chronic encephalitis and epilepsy): effect of high-dose steroids or immunoglobulins in 19 patients | Q34342831 |
| | Morvan's fibrillary chorea: remission after plasmapheresis | Q34411022 |
| | Autoantibodies detected to expressed K+ channels are implicated in neuromyotonia | Q34416092 |
| | Autoantibodies and cell-mediated autoimmunity to NMDA-type GluRepsilon2 in patients with Rasmussen's encephalitis and chronic progressive epilepsia partialis continua | Q34429867 |
| | Serum autoantibodies do not differentiate PANDAS and Tourette syndrome from controls | Q34457204 |
| | Alpha7-acetylcholine receptor antibodies in two patients with Rasmussen encephalitis. | Q34475325 |
| | Neuromyotonia and limbic encephalitis sera target mature Shaker-type K+ channels: subunit specificity correlates with clinical manifestations | Q34513708 |
| | Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression | Q34546279 |
| | Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase | Q34566310 |
| | Rasmussen's encephalitis: a role for autoimmune cytotoxic T lymphocytes. | Q34581938 |
| | Limbic encephalitis and small cell lung cancer. Clinical and immunological features | Q34741605 |
| | Hashimoto encephalopathy: syndrome or myth? | Q35064274 |
| | Autoantibodies to ion channels at the neuromuscular junction | Q35172009 |
| | Human lupus autoantibodies against NMDA receptors mediate cognitive impairment. | Q35225108 |
| | Paraneoplastic Syndromes Involving the Nervous System | Q35560941 |
| | Efficacy of rituximab (anti-CD20) for refractory systemic lupus erythematosus involving the central nervous system | Q35760171 |
| | Treatment-responsive limbic encephalitis identified by neuropil antibodies: MRI and PET correlates | Q35924577 |
| | Autoimmune limbic encephalitis in 39 patients: immunophenotypes and outcomes. | Q36143265 |
| | Human autoantibodies specific for the alpha1A calcium channel subunit reduce both P-type and Q-type calcium currents in cerebellar neurons. | Q36174877 |
| | Neuroimmunology of dancing eye syndrome in children | Q36534281 |
| | Functional characterisation of autoantibodies from patients with pediatric opsoclonus-myoclonus-syndrome | Q39216271 |
| | Surface-binding autoantibodies to cerebellar neurons in opsoclonus syndrome | Q40403389 |
| | Mechanism of action of voltage-gated K+ channel antibodies in acquired neuromyotonia | Q40519007 |
| | Analysis of antibody gene rearrangement, usage, and specificity in chronic focal encephalitis. | Q40745238 |
| | Autoantibodies to GABA-ergic neurons and pancreatic beta cells in stiff-man syndrome | Q41196484 |
| | Glutamate receptor antibodies activate a subset of receptors and reveal an agonist binding site | Q41354036 |
| | Molecular diversity of neuronal-type calcium channels identified in small cell lung carcinoma | Q41592490 |
| | Epilepsy: an autoimmune disease? | Q43071448 |
| | GluR3 antibodies: prevalence in focal epilepsy but no specificity for Rasmussen's encephalitis. | Q43775117 |
| | A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus | Q43786936 |
| | Serum autoantibodies in childhood opsoclonus-myoclonus syndrome: an analysis of antigenic targets in neural tissues | Q44188999 |
| | Autoimmune epilepsy: distinct subpopulations of epilepsy patients harbor serum autoantibodies to either glutamate/AMPA receptor GluR3, glutamate/NMDA receptor subunit NR2A or double-stranded DNA. | Q46566884 |
| | Serum antibodies in epilepsy and seizure-associated disorders | Q46848031 |
| | Temporal-lobe epilepsy associated with glutamic-acid-decarboxylase autoantibodies. | Q47670840 |
| | Anti-neuronal autoantibody in Hashimoto's encephalopathy: neuropathological, immunohistochemical, and biochemical analysis of two patients | Q48116407 |
| | Improvement in adult-onset Rasmussen's encephalitis with long-term immunomodulatory therapy. | Q48263775 |
| | Antiserum to brain gangliosides produces recurrent epileptiform activity | Q48350462 |
| | Reduction of P/Q-type calcium channels in the postmortem cerebellum of paraneoplastic cerebellar degeneration with Lambert-Eaton myasthenic syndrome | Q48414668 |
| | Peculiar labeling of cultured hippocampal neurons by different sera harboring anti-glutamic acid decarboxylase autoantibodies (GAD-Ab). | Q48454051 |
| | Antibodies to voltage-gated potassium and calcium channels in epilepsy | Q48462110 |
| | P/Q type calcium-channel antibodies in paraneoplastic cerebellar degeneration with lung cancer. | Q48489289 |
| | Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome | Q48647041 |
| | Cryptogenic partial epilepsies with anti-GM1 antibodies: a new form of immune-mediated epilepsy? | Q48911721 |
| | Autoimmunity to munc-18 in Rasmussen's encephalitis. | Q49110443 |
| | Glutamic acid decarboxylase autoantibodies in controlled and uncontrolled epilepsy: a pilot study. | Q54030379 |
| P433 | issue | 1 | |
| P921 | main subject | autoantibody | Q785022 |
| P304 | page(s) | 55-65 | |
| P577 | publication date | 2008-02-01 | |
| P1433 | published in | Autoimmunity | Q4826348 |
| P1476 | title | Autoantibody-mediated disorders of the central nervous system | |
| P478 | volume | 41 | |